Top-selling eye vitamins found not to match scientific evidence
- Details
- Category: Research
With Americans spending billions of dollars each year on nutritional supplements, researchers have analyzed popular eye vitamins to determine whether their formulations and claims are consistent with scientific findings. They determined that some of the top-selling products do not contain identical ingredient dosages to eye vitamin formulas proven effective in clinical trials.
How to create and sustain clinical-research partnerships
- Details
- Category: Research
Pragmatic clinical trials - real-life tests done in real-world settings - are increasingly important for answering pressing questions about how best to deliver health care. But these pragmatic trials require close collaboration between two professional groups who often have contrasting styles. One group is researchers, who follow structure like classical musicians.
New study strengthens evidence of the connection between statin use and cataracts
- Details
- Category: Research
Few classes of drugs have had such a transformative effect on the prevention of cardiovascular disease (CVD) as have statins, prescribed to reduce total cholesterol and low-density lipoprotein cholesterol. However, some clinicians have ongoing concerns regarding the potential for lens opacities (cataracts) as a result of statin use. In an article in the Canadian Journal of Cardiology, researchers report increased risk for cataracts in patients treated with statins.
Breast cancer vaccine shows promise in small clinical trial
- Details
- Category: Research
A breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence also suggests that the vaccine primed the patients' immune systems to attack tumor cells and helped slow the cancer's progression.
NIAID/GSK experimental Ebola vaccine appears safe, prompts immune response
- Details
- Category: Research
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH's National Institute of Allergy and Infectious Diseases (NIAID) and GlaxoSmithKline (GSK), was tested at the NIH Clinical Center in Bethesda, Maryland.
Vegetable oil ingredient key to destroying gastric disease bacteria
- Details
- Category: Research
The bacterium Helicobacter pylori is strongly associated with gastric ulcers and cancer. To combat the infection, researchers at University of California, San Diego School of Medicine and Jacobs School of Engineering developed LipoLLA, a therapeutic nanoparticle that contains linolenic acid, a component in vegetable oils.
Another reason to be thankful: turkeys may be lifesavers
- Details
- Category: Research
While the turkey you eat on Thursday will bring your stomach happiness and could probably kick-start an afternoon nap, it may also save your life one day. That's because the biological machinery needed to produce a potentially life-saving antibiotic is found in turkeys. Looks like there is one more reason to be grateful this Thanksgiving.
More Pharma News ...
- Muscle relaxant may be viable treatment for rare form of diabetes
- Only half of patients take their medications as prescribed
- Finding new ways to make drugs
- Reprogramming cells, long term
- Chemical in coffee may help prevent obesity-related disease
- Single-dose, needle-free Ebola vaccine provides long-term protection in macaques
- Reprogrammed cells grow into new blood vessels